Kukje Pharma Co Ltd Capital Reinvestment Ratio
Kukje Pharma Co Ltd capital reinvestment ratio. Kukje Pharma Co Ltd (002720) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.99 Billion) in capital expenditures (₩474.52 Million). Check Kukje Pharma Co Ltd (002720) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Kukje Pharma Co Ltd (2011–2024)
Capital reinvestment ratio of Kukje Pharma Co Ltd from 2011 to 2024. This chart tracks Kukje Pharma Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore 002720 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Kukje Pharma Co Ltd Capital Reinvestment Ratio by Year (2011–2024)
Kukje Pharma Co Ltd capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see Kukje Pharma Co Ltd (002720) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.76x | ₩3.94 Billion | ₩2.99 Billion | ▲ +159.8% |
| 2023 | 0.29x | ₩3.58 Billion | ₩1.05 Billion | ▲ +51.1% |
| 2022 | 0.19x | ₩6.50 Billion | ₩1.26 Billion | ▼ -1.8% |
| 2021 | 0.20x | ₩9.60 Billion | ₩1.89 Billion | ▼ -91.3% |
| 2020 | 2.27x | ₩5.10 Billion | ₩11.60 Billion | ▲ +39.2% |
| 2019 | 1.63x | ₩3.60 Billion | ₩5.89 Billion | ▲ +615.1% |
| 2018 | 0.23x | ₩13.25 Billion | ₩3.03 Billion | ▼ -93.1% |
| 2017 | 3.32x | ₩786.10 Million | ₩2.61 Billion | ▲ +1889.6% |
| 2016 | 0.17x | ₩16.10 Billion | ₩2.69 Billion | ▼ -83.4% |
| 2012 | 1.00x | ₩1.58 Billion | ₩1.59 Billion | ▲ +1641.9% |
| 2011 | 0.06x | ₩17.39 Billion | ₩1.00 Billion | — |